Lakeside Discovery Supports Northwestern Lab to Treat Polycystic Kidney Disease
Lakeside Discovery, LLC, the collaboration between Northwestern University and Deerfield Management, will support the laboratory of Paul DeCaen, PhD in a multi-year partnership to advance new therapies for genetically driven polycystic kidney disease.
The XX/XY Factor
A massive trove of information produced in a Northwestern-led study will lay the groundwork for understanding sex-related differences in health and disease for decades to come.
Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy
Stephen Miller, PhD, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials for work on a nanoparticle that induces gluten tolerance in celiac disease.
Northwestern Faculty Inducted into Prominent Medical Societies
Several Feinberg faculty members have been elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).
Mapping Neural Connections in Parkinson’s Disease
Imbalanced activation of cells and previously unknown neural connections may be responsible for some motor symptoms in Parkinson’s disease and similar neurodegenerative conditions, according to two recent studies.
Inhibiting SAM Biosynthesis to Slow Tumor Growth
Inhibiting production of a key material produced by the mTOR pathway could slow tumor growth, according to a recent Northwestern Medicine study.
No Pain, No Gain in Exercise for Peripheral Artery Disease
A Northwestern Medicine study has shown that a high-intensity home-based walking exercise program improved walking ability in people with peripheral artery disease.
PPA Conference Builds Connections in the Aphasia Field
More than 350 participants attended the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease’s virtual PPA Conference, which featured keynote speakers and group support sessions focused on Primary Progressive Aphasia.
Expansion of 2GETHER Project Awarded $9 Million
The Institute for Sexual and Gender Minority Health and Wellbeing has been awarded a five-year, $9 million for the expansion of the 2GETHER study, which aims to reduce HIV incidence by teaching relationship and sexual health promotion skills to young men who have sex with men.
Protein Variant May Have Potential as Target for Glioblastoma
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a recent Northwestern Medicine study.
Feinberg Investigators Discuss Impact and Evolution of COVID-19
It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.
‘Sweat Sticker’ Diagnoses Cystic Fibrosis on The Skin in Real Time
Developed by Northwestern scientists, a novel skin-mounted sticker that absorbs sweat and then changes color can provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.
Examining Rare Neurological Complications of COVID-19 in Children
The largest study to date of neurological manifestations of COVID-19 in children demonstrated patterns in the rare complications seen among pediatric patients.
Bioinformatic Computational Tool Analyzes Tissue Samples to Discern Disease
A novel integrative computational technique allowed scientists to classify disease conditions at the molecular level using epigenomic data sets.
Feinberg Rises to 15th in U.S. News Ranking for Research-Oriented Medical Schools
Northwestern University Feinberg School of Medicine has been recognized as one of the best research-oriented medical schools in the nation, rising three spots to rank an all-time high of 15th, according to the latest U.S. News & World Report rankings, released today.
Inflammation Protection May Be Critical to Treating MS
Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis, according to a recent study.
Northwestern Scientists Discover Potential Therapeutic Target for Glioblastoma
Northwestern Medicine investigators have discovered that inhibiting tumor-associated myeloid cells ability to produce specialized metabolites called polyamines may improve the effectiveness of treatments for glioblastoma.
Antibody Bolsters Immune Response to Glioblastoma
Northwestern Medicine scientists have engineered a novel antibody that revitalizes immune cell activity in a deadly brain cancer, according to a recent study.
Next-Gen Sequencing
Northwestern’s investment in next-generation sequencing is leading to unprecedented avenues of discovery.
Northwestern Medicine Scientists Track COVID-19 Variants
Since March 2020, a team of Northwestern Medicine scientists have been tracking the evolution of SARS- CoV-2, specifically in the city of Chicago. Their work has been pivotal in understanding how the virus spread to Chicago and what new variants have emerged in the city.
Conformational Switch Implicated in Neurodegenerative Diseases
Northwestern Medicine scientists have discovered a conformational “switch” that determines the function of the SNARE protein Ykt6, with implications for synucleinopathies, according to a recent study.
Immune Receptor Linked to Chronic Heart Transplant Rejection
The AXL immune cell receptor has been linked to cardiac allograft vasculopathy, a thickening of vessel walls in transplanted hearts years after implantation, according to a recent study.
Celebrating Feinberg’s 2021 Residency Match
Fourth-year students celebrated their residency matches and reflected on their Feinberg experience during a socially distant Match Day.
Medical Honor Society Welcomes 2021 Inductees
Forty-four new members were inducted into Northwestern’s chapter of the Alpha Omega Alpha medical honor society during a virtual ceremony on March 17.
Lurie Children’s Receives $4 Million to Study Lennox-Gastaut Syndrome
Northwestern and Lurie Children’s Hospital investigators have been approved for a $4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study Lennox-Gastaut Syndrome.
Department of Pharmacology Looks Ahead to New Discoveries and Collaborations
Feinberg’s Department of Pharmacology has expanded in size, faculty, and research focus, and is looking ahead to future growth in the field.
Suleiman and Youmans Honored as Leaders in Minority Health
Linda Suleiman, MD, ’17 GME, and Quentin Youmans, ’15 MD, ’18 GME, have been included in the National Minority Quality Forum’s 2021 “40 Under 40 Leaders in Minority Health” list.
Gastrointestinal Surgical Technique Linked to Lower Recurrence of Cancer
Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.
Changes in Macrophages Drive Vulnerability to Lung Infections
An age-related accumulation of a signaling molecule may be one culprit behind older adults’ vulnerability to viral pneumonias, according to a recent study.
Feinberg Students Receive Fogarty Global Health Fellowships
Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.